DK1399127T3 - Olopatadinformuleringer til topisk administration - Google Patents

Olopatadinformuleringer til topisk administration

Info

Publication number
DK1399127T3
DK1399127T3 DK02737539T DK02737539T DK1399127T3 DK 1399127 T3 DK1399127 T3 DK 1399127T3 DK 02737539 T DK02737539 T DK 02737539T DK 02737539 T DK02737539 T DK 02737539T DK 1399127 T3 DK1399127 T3 DK 1399127T3
Authority
DK
Denmark
Prior art keywords
topical administration
olopatadine formulations
olopatadine
formulations
topical
Prior art date
Application number
DK02737539T
Other languages
Danish (da)
English (en)
Inventor
Ernesto J Castillo
Wesley Wehsin Han
Huixiang Zhang
Haresh G Bhagat
Onkar N Singh
Joseph Paul Bullock
Suresh C Dixit
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23162841&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1399127(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1399127T3 publication Critical patent/DK1399127T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02737539T 2001-06-27 2002-06-19 Olopatadinformuleringer til topisk administration DK1399127T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27
PCT/US2002/019417 WO2003002093A1 (en) 2001-06-27 2002-06-19 Olopatadine formulations for topical administration

Publications (1)

Publication Number Publication Date
DK1399127T3 true DK1399127T3 (da) 2005-06-13

Family

ID=23162841

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02737539T DK1399127T3 (da) 2001-06-27 2002-06-19 Olopatadinformuleringer til topisk administration

Country Status (21)

Country Link
US (2) US6995186B2 (zh)
EP (1) EP1399127B1 (zh)
JP (5) JP4827374B2 (zh)
KR (1) KR100884711B1 (zh)
CN (1) CN1211125C (zh)
AR (1) AR034619A1 (zh)
AT (1) ATE295149T1 (zh)
AU (1) AU2002310461B2 (zh)
BR (1) BRPI0210707B8 (zh)
CA (1) CA2447924C (zh)
DE (1) DE60204142T2 (zh)
DK (1) DK1399127T3 (zh)
ES (1) ES2238574T3 (zh)
GC (1) GC0000397A (zh)
HK (1) HK1059573A1 (zh)
MX (1) MXPA03011947A (zh)
PL (1) PL205565B1 (zh)
PT (1) PT1399127E (zh)
TW (1) TWI231759B (zh)
WO (1) WO2003002093A1 (zh)
ZA (1) ZA200308771B (zh)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
KR20120136430A (ko) * 2004-04-08 2012-12-18 교와 핫꼬 기린 가부시키가이샤 안정성이 향상된 고형 제제 및 그 제조 방법
EP1757285A4 (en) * 2004-04-21 2007-11-07 Kyowa Hakko Kogyo Kk PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CHRONIC SINUSITIS
EP1761259A2 (en) * 2004-06-28 2007-03-14 Alcon Inc. Topical formulations for treating allergic diseases
WO2006057769A2 (en) * 2004-11-24 2006-06-01 Alcon, Inc. Method of delivering nasal spray
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US8101654B2 (en) 2005-07-08 2012-01-24 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
EP2091514B1 (en) * 2006-11-09 2013-06-05 Alcon Research, Ltd. Water insoluble polymer matrix for drug delivery
CN101563051A (zh) * 2006-12-18 2009-10-21 爱尔康研究有限公司 眼用药物递送的装置与方法
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
SI2114367T1 (sl) * 2007-02-07 2016-01-29 Novartis Ag Formulacije olopatadina za topično nazalno dajanje
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
MX2009010946A (es) * 2007-04-11 2009-10-29 Alcon Res Ltd Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica.
WO2009031682A1 (ja) 2007-09-06 2009-03-12 Kyowa Hakko Kirin Co., Ltd. ジベンゾ[b,e]オキセピン誘導体含有点眼剤
RU2010151994A (ru) * 2008-05-19 2012-06-27 Алькон Рисерч, Лтд. (Us) Фармацевтические композиции, включающие карбоксивинильный полимер и повидоновый полимер
CN102089039B (zh) * 2008-08-26 2013-10-23 博磊科技股份有限公司 带静电荷口罩过滤产品和用于增加过滤效率的方法
KR20110056526A (ko) * 2008-08-28 2011-05-30 트루텍 코프. 항히스타민 및 유사-항히스타민 코 외용약, 생성물 및 방법
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
AU2010273347B2 (en) * 2009-07-17 2015-04-30 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
WO2011038066A2 (en) * 2009-09-25 2011-03-31 Alcon Research, Ltd. Novel npr-b agonists
CN105732767A (zh) 2009-09-25 2016-07-06 夏尔孤儿治疗有限公司 新的npr-b激动剂
CN102548536A (zh) * 2009-10-01 2012-07-04 爱尔康研究有限公司 奥洛他定组合物及其用途
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
TW201121995A (en) 2009-12-18 2011-07-01 Alcon Res Ltd Novel NPR-B agonists
CA2805656A1 (en) * 2010-07-21 2012-01-26 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
WO2012063237A2 (en) * 2010-11-08 2012-05-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
MA47418A (fr) 2017-02-01 2021-06-02 Takeda Pharmaceuticals Co Composés et compositions pour le traitement de troubles ophtalmiques
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
CA3160570A1 (en) * 2019-12-06 2021-06-10 Taizou Kamishita Rhinenchysis composition containing olopatadine
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
EP0316633B1 (de) * 1987-11-13 1993-01-27 ASTA Medica Aktiengesellschaft Azelastin enthaltende Arzneimittel zur Anwendung in der Nase und/oder am Auge
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU7833698A (en) * 1997-06-09 1998-12-30 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
PT1037627E (pt) 1998-07-14 2001-11-30 Alcon Lab Inc Utilizacao do acido 11-(3-dimetilaminopropilideno)-6,11-dihidrodibenz¬b,e|oxepin-2-acetico e seus sais derivados farmaceuticamente aceitaveis para a producao de um medicamento para o tratamento de doencas inflamatorias oftalmicas nao-alergicas e para a prebencao da neovascularizacao ocular
US6146622A (en) 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
ES2187203T3 (es) * 1998-10-27 2003-05-16 Alcon Lab Inc Sistema conservante para composiciones farmaceuticas administrables topicamente que contiene un jabon de acido graso/aminoacido.
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) * 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
CA2391976A1 (en) 1999-09-21 2001-03-29 Ernesto J. Castillo Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
MXPA02005007A (es) 1999-11-18 2004-08-12 Alcon Inc Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
EP1250133B1 (en) * 2000-01-25 2005-03-30 Alcon Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
AU2003291497B2 (en) 2002-11-12 2007-12-20 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis

Also Published As

Publication number Publication date
TWI231759B (en) 2005-05-01
BRPI0210707B1 (pt) 2015-08-04
ZA200308771B (en) 2005-01-26
DE60204142D1 (de) 2005-06-16
ES2238574T3 (es) 2005-09-01
JP4827374B2 (ja) 2011-11-30
HK1059573A1 (en) 2004-07-09
EP1399127A1 (en) 2004-03-24
CN1211125C (zh) 2005-07-20
AR034619A1 (es) 2004-03-03
PL205565B1 (pl) 2010-05-31
JP2013127005A (ja) 2013-06-27
AU2002310461B2 (en) 2006-05-18
ATE295149T1 (de) 2005-05-15
CA2447924A1 (en) 2003-01-09
EP1399127B1 (en) 2005-05-11
JP2010150292A (ja) 2010-07-08
KR20040025919A (ko) 2004-03-26
JP2004536096A (ja) 2004-12-02
PT1399127E (pt) 2005-07-29
BRPI0210707B8 (pt) 2021-05-25
BR0210707A (pt) 2004-07-20
PL367780A1 (en) 2005-03-07
WO2003002093A1 (en) 2003-01-09
US6995186B2 (en) 2006-02-07
JP2009114213A (ja) 2009-05-28
KR100884711B1 (ko) 2009-02-19
CN1525849A (zh) 2004-09-01
US20050158387A1 (en) 2005-07-21
JP5328947B2 (ja) 2013-10-30
US20030055102A1 (en) 2003-03-20
US7402609B2 (en) 2008-07-22
DE60204142T2 (de) 2005-10-06
GC0000397A (en) 2007-03-31
CA2447924C (en) 2009-11-03
MXPA03011947A (es) 2004-03-26
JP2012107046A (ja) 2012-06-07

Similar Documents

Publication Publication Date Title
DK1399127T3 (da) Olopatadinformuleringer til topisk administration
NO20033556L (no) Farmasöytiske formuleringer
NO20033384D0 (no) Farmasöytisk formulering
ITTO20010008A0 (it) Formulazione farmaceutica
FI20011478A (fi) Farmaseuttinen koostumus
AR028291A1 (es) Formulaciones oftalmicas
PT1501534E (pt) Formulacoes farmaceuticas
NO20033785L (no) Farmasöytisk formulering
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
IS2580B (is) Platínuafleiða lyfjasamsetningar
ITMI20010748A0 (it) Composizioni farmaceutiche
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
NO20026123L (no) Farmasöytiske sammensetninger
DE60218346D1 (de) Stabilisierte topische brivudin-formulierungen
NO20034556D0 (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20031095D0 (no) Farmasöytiske sammensetninger
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DE60235195D1 (de) Vitamin-d-analoga
EE200200689A (et) Ravimkoostised
NO20041236L (no) Farmasoytisk formulering
SE0101325D0 (sv) Pharmaceutical formulation
SE0101171D0 (sv) Pharmaceutical formulation